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Oral movement disorders may lead to prosthesis and implant failure due to excessive loading. We report on an edentulous patient
suffering from drug-induced tardive dyskinesia (TD) and oral parafunction (OP) rehabilitated with implant-supported screw-
retained prostheses. The frequency and intensity of the movements were high, and no pharmacological intervention was possible.
Moreover, the patient refused night-time splint therapy. A series of implant and prosthetic failures were experienced. Implant
failures were all in the maxilla and stopped when a rigid titanium structure was placed to connect implants. Ad hoc designed
studies are desirable to elucidate the mutual influence between oral movement disorders and implant-supported rehabilitation.
1. Introduction
Tardive dyskinesia (TD) is characterised by involuntary, repe-
titive, and purposeless movements, which may involve chew-
ing motions, cheek puffing, tongue protrusion, and lip purs-
ing. Movements of other body segments may also occur,
and symptoms may appear during sleep and/or wakefulness
[1, 2]. Most often TD represents a side effect of antipsychotic
medications [3, 4]. Typical and, at a lower rate, atypical anti-
psychotics may induce TD probably by increasing dopamine
sensitivity in the nigrostriatal pathway, especially for D2
dopamine receptor [5–9]. Other drugs, as antiemetic meto-
clopramide and antidepressants, have been linked to TD,
although with much lower frequency [10–13]. It is important
to underline the fact that these drugs are capable of inducing
diversemovement disorders, as dystonia [14],myoclonus [15],
“rabbit syndrome” [16], and sleep bruxism [17]. The latter
has been linked particularly to selective serotonin reuptake
inhibitors (SSRIs) [18, 19].
The term “tardive” was originally used to indicate the
most frequent timing of dyskinesia onset, after at least 3
months of therapy. However, the appearance of dyskinetic
symptoms is not dose-related and may occur either after a
short or a long time of drug use, and it is generally accepted
that most patients will eventually fall ill with the disorder if
they remain on neuroleptics long enough.
Oral parafunctions (OP) include many activities occur-
ring during the awake state, the commonest being prolonged
steady mandibular postures and jaw clenching [20].They can
be classified in primary, or idiopathic, and secondary, when
they originate from a neurological or psychiatric disease or
represent a side effect of a medication or a recreational drug.
Alcohol intake and cigarette smoking may also contribute
[21]. They have been associated with psychiatric disorders as
well as psychosocial factors like stress and anxiety [22–24].
TD may have dental implications, as it causes attritions
and abfractions on natural teeth [25, 26]. It also represents a
risk factor for the prosthetic management of the patient,
worsening the stability of complete dentures and increasing
the risk of prostheses breaks. Additionally, TD-provoking
drugs can induce changes of salivary flow, which worsen
patient’s adaptation to removable prostheses [27–30]. Imp-
lant-supported fixed rehabilitation may appear as a valuable
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Figure 1: Orthopantomography of the patient at first visit (a), 18 weeks (b), and 96 weeks (c).
therapeutic option, as it improves prostheses stability and has
positive psychosocial effects [31, 32]. However, oral move-
ment disorders may cause excessive load of the prostheses,
which in turn may affect implant outcome [33, 34], and jeo-
pardise simple or complex rehabilitative procedures and tar-
dive dyskinesia represents a particularly critical situation for
implant rehabilitation [35, 36].
We here report a case of implant-supported fixed rehabi-
litation in an edentulous patient with extreme loading condi-
tions due to TD and OP.
2. Case Presentation
A 58-year-old Caucasian man complaining of unsatisfactory
removable prostheses was admitted to the dental clinic.
Remote anamnesis revealed history of alcohol abuse asso-
ciated with impulsive behaviour, with the start of medical
therapies dating back to 2004. The patient was at that time
suffering from major depression and narcissistic personality
disorder and was administered a multiple pharmacotherapy.
He was treated with Citalopram 40mg/day, aimed at control-
ling depression, from 2004 to 2007; an occasional treatment
with Paroxetine 30 mg/day was performed in 2004 for 90
days. During the same year, the patient took Promethazine
25mg/day. Valproic acid 1 g/day and Oxcarbazepine 1.2 g/day
were prescribed up to now as anticonvulsants.Thepatientwas
also administered benzodiazepines: Lorazepam 2.5mg/day
from 2004 to 2006, Triazolam 0.25mg/day, and Diazepam
2mg/day from 2005 to 2006. A temporary treatment with the
second-generation antipsychotic Olanzapine 5mg/day was
carried out for 90 days in 2005. The patient also assumed
Trazodone 75mg/day. In 2007, the antidepressant Venlafax-
ine substituted Citalopram, with doses increasing to the
current posology of 150mg/day. Clonazepam 5mg/day was
administered since 2007, substituting previously used ben-
zodiazepines. In 2008, the patient received Hydroxyzine
25mg/day. During 2011, Zolpidem 4mg/day was prescribed
to the patient. Olanzapine 5mg/day was permanently rein-
troduced into the therapy in April 2012.
The patient has been suffering from TD as a side effect of
drugs since 2009. The involuntary movements he presented
were repetitive stereotyped chewingmotions and lip protrud-
ing.Themovements were probably present also during sleep,
but the patient did not accept further ambulatory sleep study.
OPwas also evident, as prolonged steadymandibular pos-
tures and habit of teeth clenching: these activities, differently
from the repetitive movements of TD, could be voluntarily
stopped and were exacerbated in state of psychological
anxiety.
The patient had been smoking 20 cigarettes/day since
many years.
Clinical examination of the oral cavity revealed the pres-
ence of 2 residual teeth in themaxilla (canines) and 4 residual
teeth in the mandible (2 canines and 2 premolars), restored
with post and ball attachment to, respectively, stabilise max-
illary and mandibular overdentures. All teeth were affected
by severe reduction of periodontal support and showed class
III mobility. Marked gingival inflammation was also evident.
Orthopantomography attested horizontal bone loss around
the remaining teeth and generalised vertical atrophy of the
alveolar processes (Figure 1(a)).
Treatment consisted of extraction of the remaining hope-
less teeth (time: T0) and subsequent full mouth rehabilitation
with implant-supported fixed prostheses. After thorough
discussion, the patient approved this therapeutic option.
Twelve weeks following T0, a CT scan (Siemens Somatom
Emotion 6; Siemens, Erlangen, Germany) was performed
to plan implant insertion (NobelGuide planning software;
Nobel Biocare, Go¨teborg, Sweden). Two weeks later, the
patient underwent bilateral sinus lift with lateral window
approach. Autologous bone chips plus deproteinised bovine
bone granules (Bio-Oss; Geistlich Pharma AG, Wolhusen,
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Figure 2: Final prostheses delivered to the patient at 96 weeks.
Switzerland) were used as grafting materials. In the course of
the same surgical intervention, six dental implants (NobelRe-
place, Nobel Biocare, Go¨teborg, Sweden, as all the remaining
implants employed) were placed in the maxilla with an
insertion torque > 30N/cm. The patient was provided with
a provisional complete denture to wear during the planned
24-week healing period.
The mandible was rehabilitated 18 weeks after T0 by
means of 6 dental implants inserted with a torque > 40N/cm
and immediately restored with a provisional screw-retained
acrylic bridge. The implants were all 10mm long and 4.3
diameter, except the 4.6 implant, which had a 5mm diameter
(Figure 1(b)). A group function occlusal scheme was created,
with accurate control of contacts in intercuspal position and
lateral and protrusive movements. This occlusal scheme was
maintained in both provisional and final prostheses.
At 32 weeks, a complete mandibular implant-supported
screw-retained prosthesis was finalised with composite teeth
and milled titanium framework.
At 36 weeks, the implant in 1.1 position failed. At a routine
control visit, the implant was exposed and mobile, with no
symptoms. It was therefore removed and substituted with a
larger implant. At the same time point, the remaining maxil-
lary implants were loaded with a provisional implant-sup-
ported screw-retained acrylic prosthesis.
Four weeks later (at 40-week time point), the implants in
2.2 and 2.6 positions failed, with no apparent sign of infection.
The implant in 2.2 site was replaced with a larger one. This
was not possible for the 2.6 implant; thus an implant was
inserted more distally, in 2.7 position. An additional implant
was placed in 1.7. A provisional acrylic bridgewas then placed,
using all the maxillary implants.
At 44 weeks, the implant in 2.4 site showed severe
marginal bone loss on the vestibular side, whichwasmanaged
by means of a deproteinised bovine bone granular graft (Bio-
Oss; Geistlich Pharma AG, Wolhusen, Switzerland). Despite
this intervention, the implant failed at 48 weeks and was
replaced with a longer implant, inserted apically. Another
implant was positioned in the adjacent 2.3 area.
At the followingmonthly follow-up visits, the provisional
maxillary bridge frequently showed cracks, which underwent
mostly unnoticed by the patient. All cracks could be repaired.
At 60 weeks, the maxillary acrylic bridge broke into two
pieces, and implants 2.4 and 2.7 were removed, due to their
loss of osseointegration in the absence of infection signs.
Implants were placed in 2.6 and 2.7 sites. A new acrylic full
arch bridge was screwed to all the maxillary implants.
At 72 weeks, the patient was provided with a maxillary
screw-retained prosthesis with composite teeth and milled
titanium framework (Figures 2(a) and 2(b)). From this
moment to the 96-week follow-up visit, no further maxillary
implant was lost and the prosthesis performed satisfactorily.
A time course of maxillary implant insertions and failures is
described in Figure 3.
At 96 weeks, all mandibular implants were successful
(Figure 1(c)), as they had good stability and showed no
marginal bone loss, no inflammation, nor any symptoms.The
mandibular full arch bridge performed adequately during the
whole examination period, showing some sign of attrition.
TD appeared as a permanent condition during the obser-
vation period. It was not possible to prescribe a pharmaco-
logical therapy specifically aimed at controlling TD due to
the underlying psychiatric disease of the patient. The patient
refused night splint therapy.
Massive efforts to teach self-control of OP were under-
taken, but the effect was highly variable in time and, overall,
poor.
3. Discussion
Oral parafunctions may alter occlusal loads of natural teeth,
prostheses, and dental implants, both in terms of force direc-
tion and intensity. Dental attrition, abfraction, and occlusal
pits on natural teeth have been documented in patients with
self-reported parafunctions. Many authors suggested that
oral parafunctions represent a risk factor for marginal bone
loss around implants and implant failure [37–40].
TD and other oral movement disorders can similarly
generate increased tooth or implant loads. A case of traumatic
granulomatous tissue at the implant site of a patient with
TD has been reported [41]. Other studies showed successful
results of implant-retained overdentures in patients with
neurological movement disorders involving oral and perioral
areas [35, 36, 42–46].
As a matter of fact, the influence of increased load on
implants still represents a matter of debate and no clear-cut
conclusion can be drawn from the published literature [47–
54].This is in part due to the inherent difficulty in quantifying
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Figure 3: Time course ofmaxillary implant insertions and failures, ordered by position. In red a given implant first positioning and in blue the
substituting implant.The initial planning included 6 implants with delayed loading. Five implants failed.Themaxilla was finally rehabilitated
at 72 weeks with a screwed titanium milled framework with acrylic composite teeth supported by 8 implants. No additional implant failures
occurred.
the load transferred to implants in a clinical setting. In the
present case, all implant failures occurred in absence of
infection. They were likely due to the extreme mechanical
loads caused by coexisting severe TD and OP.
The different survival rate ofmaxillary versusmandibular
implants (57% versus 100%) may be related to different
factors. The anatomical characteristics of the jaws arguably
play a role, the mandible being mainly composed of corti-
cal compact bone. The literature has consistently reported
high implant success rates in the mandible, also employing
immediate loading protocols. Maxillary bone is generally less
favourable, due to its lower density and higher amount of
trabecular bone [55, 56], which may hinder the rehabilitation
techniques that are applied [57, 58]. Moreover, sinus lift inter-
ventions and grafted materials used may play an influence
on implant outcome [59, 60]. In our case, implants placed
in areas of sinus lifts were successful in 1.6 and 1.7 positions,
while they failed on the opposite side in 2.6 and 2.7 positions.
Prosthetic aspects are of the utmost importance in deter-
mining the load transfer to implants. Unfortunately, as of
today, there is no clear evidence-based concept of “ideal
occlusal scheme” to apply in implant-supported prosthodon-
tics [61, 62]. A review assessed the importance of decreasing
cuspal interferences, centralising forces along implant axes
and avoiding cantilevers [63]. Klineberg recommended an
occlusal design with narrow occlusal table, with central fossa
loading in intercuspal contact and low cusp inclination [64,
65]. Occlusal canine guidance instead of group function in
patients with OP has also been proposed [66].
Prosthetic breaks represent one of the commonest com-
plications in the rehabilitation of patients suffering from oral
parafunctions: it has been reported that ceramic crowns have
high risk of fracture, especially when they articulate one with
the other [67, 68]. Skalak first hypothesised that resilient pro-
sthetic materials help reducing overloads and so recommen-
ded the use of acrylic resin teeth in implant-supported pros-
theses [69]. Others proposed to use a metal occlusal surface,
which combine resiliency and resistance properties [70].
In this case, the patient frequently broke the unreinforced
acrylic resin maxillary full arch prosthesis. Such loss of
integrity may have represented a further cause of mechanical
stress build-up at certain implant areas, together with the
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inherent flexibility of this type of prosthesis. We believe that
the latter characteristic was of the utmost importance, since
implant failure stopped after installing a prostheses with rigid
titaniummilled framework.This was probably due to a better
load distribution among implants. It is also possible that
specific implant surfaces may prove better suitability to with-
stand abnormal mechanical loads [71], and this aspect should
be further explored. This could be consistent with a previous
report by Amornvit et al. showing a successful implant reha-
bilitation with a balanced occlusal scheme, which may have
compensated the excessive occlusal loading [36].Thepatient’s
personal history as a heavy smoker should also be considered,
as smoke has been shown to be related to risk for and severity
of bruxism [72, 73] and may have affected the severity of the
symptoms, but may also have impacted on implant survival
as smoke has been associated with increased implant failure
and complications [74–77].
We conclude that abnormal occlusal loads related to TD
and OP played a key role in determining repeated prosthetic
breaks and implant failures in the present case. The use of a
bridgewith a rigid framework stopped implants failures. Lon-
gitudinal controlled studies to investigate implant-supported
rehabilitation in TD and other extreme load-generating
movement disorders are needed.
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